TCL Archive In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists January 20, 1984
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation March 19, 1993
TCL Archive NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner. June 2, 2006